您好,欢迎访问江苏省农业科学院 机构知识库!

Enhanced Immune Responses in Mice Induced by the c-di-GMP Adjuvanted Inactivated Vaccine for Pseudorabies Virus

文献类型: 外文期刊

作者: Hou, Liting 1 ; Yu, Xiaoming 1 ; Zhang, Yuanyuan 1 ; Du, Luping 1 ; Zhang, Yuanpeng 1 ; Cheng, Haiwei 1 ; Zheng, Qisheng 1 ; Chen, Jin 1 ; Hou, Jibo 1 ;

作者机构: 1.Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing, Peoples R China

2.Jiangsu Acad Agr Sci, Inst Vet Immunol & Engn, Nanjing, Peoples R China

3.Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China

4.Minist Sci & Technol, Jiangsu Key Lab Food Qual & Safety State Key Lab, Nanjing, Peoples R China

关键词: c-di-GMP; PRV inactivated vaccine; long-term humoral immunity; T follicular helper (Tfh) cells; germinal center (GC) B cell

期刊名称:FRONTIERS IN IMMUNOLOGY ( 影响因子:8.786; 五年影响因子:8.876 )

ISSN: 1664-3224

年卷期: 2022 年 13 卷

页码:

收录情况: SCI

摘要: Cyclic dimeric guanosine monophosphate (c-di-GMP) is a bacterial second messenger with immunomodulatory activities in mice, suggesting potential applications as a vaccine immunopotentiator or therapeutic agent. In this study, we evaluated the efficacy of c-di-GMP as an immunopotentiator for pseudorabies virus (PRV) inactivated vaccine in a murine model. We found that c-di-GMP improved the humoral and cellular immune responses induced by PRV inactivated vaccine and its effects on immunity reached the level comparable to that of a live attenuated vaccine. Furthermore, c-di-GMP enhanced the murine antibody response against the viral glycoprotein gB up to 120 days after immunization. The c-di-GMP-adjuvanted PRV inactivated vaccine induced long-term humoral immunity by promoting a potent T follicular helper cell response, which is known to directly control the magnitude of the germinal center B cell response. Furthermore, the c-di-GMP enhanced the response of bone marrow plasma cells and upregulated the expression of Bcl-2 and Mcl-1, which have been identified as anti-apoptotic regulatory genes of germinal center and memory B cells. Our findings open a new avenue for improving the immune efficacy of PRV inactivated vaccines.

  • 相关文献
作者其他论文 更多>>